Mount Yale Investment Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,289
Closed -$260K 469
2022
Q2
$260K Buy
2,289
+158
+7% +$18.1K 0.03% 386
2022
Q1
$276K Buy
2,131
+574
+37% +$82.7K 0.03% 385
2021
Q4
$281K Sell
1,557
-19
-1% -$3.3K 0.03% 390
2021
Q3
$234K Buy
1,576
+32
+2% +$4.9K 0.03% 413
2021
Q2
$234K Buy
+1,544
New +$215K 0.03% 379

Other funds holding OMCL

Mount Yale Investment Advisors's OMCL Position: Q3 2022 in Review

Mount Yale Investment Advisors sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 2,289 shares — an estimated $260K sold.

Mount Yale Investment Advisors first reported a position in OMCL in Q2 2021 and held it in 5 quarters. The position peaked at $281K in Q4 2021. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

  • Mount Yale Investment Advisors reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 2,289 Omnicell shares in Q3 2022, an estimated $260K.
  • Mount Yale Investment Advisors first reported a position in Omnicell in Q2 2021 and held it in 5 quarters.
  • Mount Yale Investment Advisors's Omnicell position peaked at $281K in Q4 2021.
  • 374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.